/People

Nick Lenard

Investor

Analyst, Public Equity at Sofinnova Ventures

Find your path to Nick

Sign up to see every warm intro you have to Nick

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Nick. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Nick Lenard joined Sofinnova BioEquities as an Analyst in 2025, where he works on public investments in biotechnology and pharmaceutical companies globally. He previously spent over four years on the sell side covering SMid and Large Cap Biotechnology, most recently as a Vice President at J.P. Morgan. He holds an M.A. in Biotechnology from Columbia University and a B.A. in Chemistry from Kenyon College.

Invests in

Biotech

Colleagues at Sofinnova Ventures

Frequently asked questions

Who is Nick Lenard?
Nick Lenard joined Sofinnova BioEquities as an Analyst in 2025, where he works on public investments in biotechnology and pharmaceutical companies globally. He previously spent over four years on the sell side covering SMid and Large Cap Biotechnology, most recently as a Vice President at J.P. Morgan. He holds an M.A. in Biotechnology from Columbia University and a B.A. in Chemistry from Kenyon College.
Where does Nick Lenard work?
Nick Lenard is Analyst, Public Equity at Sofinnova Ventures.
What does Nick Lenard invest in?
Nick Lenard invests in Biotech.

About this profile. Compiled from public sources — Sofinnova Ventures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights